Patch Test Certificate: BBlunt Curl-Defining Leave-In Cream - Dermatologically Safe & Non-Irritant
BBlunt Curl-Defining Leave-In Cream was evaluated for Primary Skin Irritation on human subjects at Cliantha Research (Selvius Research), an independent clinical research facility, under the direct supervision of a consultant dermatologist. The study (Protocol No. C3B03444, dated 08 February 2024) certified the product as Dermatologically Safe for use and Non-Irritant. This page publishes the complete certificate, the study details, and the standards followed.
What Is a Patch Test Certificate?
A patch test is a dermatological safety assessment in which a product is applied to the skin of human volunteers under controlled clinical conditions and observed for signs of irritation or allergic reaction. The study is conducted by an independent laboratory, after Ethics Committee approval, under the direct supervision of a qualified dermatologist.
A patch test certificate is the formal document issued by the testing laboratory stating the outcome of that study. It tells you three things: who tested the product, how it was tested, and what the result was. For BBlunt Curl-Defining Leave-In Cream, all three are published in full on this page.
Certificate Result: Dermatologically Safe & Non-Irritant
BBlunt Curl-Defining Leave-In Cream, manufactured by Honasa Consumer Ltd., underwent Primary Skin Irritation Testing on human subjects at Cliantha Research | Selvius Research (Clinical Research and Analytics). The study was carried out upon Ethics Committee approval under the direct supervision of Dr. Bhagirath Patel, M.D., DVL, Consultant Dermatologist, with Dr. Parth Joshi as Principal Investigator.
Based on the study - Protocol No. C3B03444, Sub Study No. C3B03444-HON-G, dated 08 February 2024 - the product was found to be Dermatologically Safe for use and Non-Irritant. The clinical study followed Bureau of Indian Standards (BIS) guidelines, including IS 4011 (2018) PCD 19: Cosmetics (third revision) and IS 13424:2001.
Key Certificate Details
| Attribute | Detail |
|---|---|
| Product Tested | BBlunt Curl-Defining Leave-In Cream |
| Company | Honasa Consumer Ltd. |
| Testing Laboratory | Cliantha Research | Selvius Research (Clinical Research and Analytics) |
| Test Type | Primary Skin Irritation Testing on human subjects |
| Ethics Approval | Conducted upon Ethics Committee approval |
| Study Protocol No. | C3B03444 |
| Sub Study Number | C3B03444-HON-G |
| Certificate Date | 08 February 2024 |
| Result | Dermatologically Safe for use; Non-Irritant |
| Principal Investigator | Dr. Parth Joshi |
| Consultant Dermatologist | Dr. Bhagirath Patel, M.D., DVL |
| Standards Followed | BIS IS 4011 (2018) PCD 19: Cosmetics (third revision); CHD 25: Soaps and Other Surface Active Agents; IS 13424:2001 |
The Certified Product
BBlunt Curl-Defining Leave-In Cream
Certified Dermatologically Safe for use; Non-Irritant in an independent clinical study - see the full ingredient list, offers and reviews on the product page.
Shop NowAbout BBlunt Curl-Defining Leave-In Cream
BBlunt Curl-Defining Leave-In Cream is part of BBlunt's dermatologically tested product line. Every safety claim on this page is backed by the certificate published above - including the study protocol number, the testing standards, and the supervising dermatologist's certification.
Independently Tested
Evaluated on human subjects at an independent laboratory after Ethics Committee approval - not self-certified.
Dermatologist Supervised
The clinical study was conducted under the direct supervision of a qualified consultant dermatologist.
BIS-Guideline Study
Testing followed Bureau of Indian Standards protocols, including IS 4011 (2018) for cosmetics.
Certificate Published in Full
The original certificate image and complete transcription are on this page - nothing summarized away.
View the Original Certificate
Patch Test Certificate issued by Cliantha Research | Selvius Research - Study Protocol No. C3B03444, dated 08 February 2024.
Full Certificate Text
Read the complete certificate transcription
(5)
yYy
) )=(5 SISIIINSSI SII ISIS III II IIIS III ISIS II ISI III II ISIS II IIIS III III III II III ISIS SI ISIS IISSISISISISI
EFI III III ISSISISI IIIS ID <6
SLID
cliantha | S@lvius
FASACICCH) | aanicar neseancn ano anatynes
Study Protocol No.: C3B03444
Sub Study Number: C3B03444-HON-G Date: 08 Feb 24
IS ISI SII SSSI IIIS ISS IS III ISI III IIS
SISISISIIS SSSI SSI I SI ISIS III IIIS SEIS ISIE ISIS III IIIS
This is to certify that
Bblunt Curl- Defining Leave-In Cream 150 Gm of Honasa Consumer Ltd. was
evaluated upon Ethics Committee Approval for Primary Skin Irritation Testing
on human subjects and was found to be
Dermatologically Safe for use
Non-lrritant
a Dr. Bhagirath Patel Dr. Parth Joshi
M.D. DVL (Dermatologist and Principal Investigator
Investigator)
Note: The Clinical study was conducted as per BIS (Bureau of Indian Standards) guidelines [IS 4011 (2018) PCD 19: Cosmetics) guidelines, third revision and/or
CHD 25: Soaps and Other Surface Active Agents Sectional Committee [first revision and IS 13424:2001 Safety evaluation of bathing bars and toilet soaps], under
the direct supervision of Dermatologist and Principal Investigator.
LI SIIISISISISSS IIIS SSSI SII IIIS SSIS ISIS III I III ISI III IIIS III IIS
yet)
(LLL EDIE ELSISISSISIISII ISIS SI IIS IIIS ISI II ISAS IS IIS IIS IIIS ISI AISI SSI IIIS IIS IIS I ISI IIIS SIS III IIIS III IIIS aK
Important Points to Know Before Use
1. Even gentle formulations can trigger existing allergies - a personal patch test is recommended before first use.
2. In case of any rashes or allergy, discontinue use and consult a specialist.
3. For external use only. Store in a cool and dry place, away from direct sunlight.
Frequently Asked Questions
A: Yes. It underwent Primary Skin Irritation Testing on human subjects (Study Protocol No. C3B03444) and was certified Dermatologically Safe for use; Non-Irritant.
A: It is the formal document issued by the testing laboratory stating who tested the product, how it was tested, and the outcome. The original image and full transcription are published on this page.
A: The study was conducted under the direct supervision of Dr. Bhagirath Patel, M.D., DVL (Consultant Dermatologist), with Dr. Parth Joshi as Principal Investigator, after Ethics Committee approval.
A: The clinical study followed Bureau of Indian Standards (BIS) guidelines, including IS 4011 (2018) PCD 19 for cosmetics, and was carried out after Ethics Committee approval.
A: Yes. Certificate results reflect testing on a sample group under clinical conditions, and individual skin can react differently. Apply a small amount on your inner arm, wait 24 hours, and check for any reaction before regular use.
Shop BBlunt Curl-Defining Leave-In Cream
You've seen the certificate - clinically evaluated, dermatologist-supervised, and certified Non-Irritant. See the full ingredient list, offers, and reviews on the product page.
Delete Your Account
Deleting your account will permanently remove your personal data, app activity, and any associated information. This action cannot be undone. To proceed, please verify your identity by entering your registered email address or phone number below. We’ll send you a confirmation link or code to complete your account deletion request.
